Although the exact mechanism by which COPD increases the risk of CVD remains unclear, previous studies have found that patients with COPD often exhibit elevated levels of systemic inflammatory biomarkers, such as C-reactive protein, IL-6, and fibrinogen, which can predict the risk of CVD in both the general population and patients with COPD (27). Here, IL6 is linked to chronic obstructive pulmonary disease.